Leadership Team
Meet iSpecimen's experienced leadership team with a shared commitment to our mission.
Tracy Wilson Curley
Interim Chief Executive Officer & Chief Financial Officer
Tracy is an experienced, results-oriented business builder focused on leading iSpecimen’s vision for progressive financial performance, expansion and growth in today’s dynamic healthcare and biotechnology research markets.
Tracy brings three decades of experience in public accounting and corporate finance for both publicly traded companies and emerging companies like iSpecimen. Before joining iSpecimen, Tracy served as a partner at CohnReznick LLP, a national accounting firm, where she led the creation and development of an emerging markets commercial audit practice team focused on recruiting and providing audit services to private and public emerging growth companies in the technology and life sciences industries. Earlier, and as a partner at Marcum LLP, a national accounting firm, Tracy led the northeast regional high-tech practice for the firm with a focus on expanding the client base to provide a full range of accounting, tax and advisory services for private and public emerging growth companies in high tech industries such as technology, life sciences and advanced manufacturing. Tracy has also served as a partner at Moody, Famiglietti & Andronico, LLP (MFA), a proactive, Boston-based consulting firm with national and global reach, where she led the creation and development of a public company audit practice focused on recruiting and providing audit services to public emerging growth companies.
Tracy received her Master of Accountancy and Bachelor of Science in Business Administration with a concentration in accounting from Kansas State University. She also attended the United States Military Academy. She is a certified public accountant licensed in the Commonwealth of Massachusetts.
Tracy Wilson Curley
Chief Executive Officer
Benjamin Bielak
Chief Information Officer
Ben brings 25 plus years of executive and senior information technology experience to iSpecimen. In his role at iSpecimen as Chief Information Officer, Ben is responsible for technology delivery and data strategy and services. He most recently served as the Chief Information Officer at GNS Healthcare, a leading casual machine learning product and services company, and as Director of Academic Technology at Harvard University. Prior to his work at GNS and Harvard, Bielak was the Chief Information Officer at Dovetail Health, a high-growth product and services company focused on reducing costs through pharmacy-focused interventions. He previously held roles as Manager of Development and Integration at Boston Medical Center and Senior Manager of Technology at Sapient.
Bielak holds a Master of Business Administration degree from Bentley University, where his studies focused on change management, and a master’s degree from Boston University in computer science. He maintains two certifications, the College of Healthcare Information Management Executives (CHIME) Certified Healthcare Chief Information Officer (CHCIO) and the Health Information Management System Society (HIMSS) Certified Professional in Healthcare Information and Management Systems (CPHIMS).
Benjamin Bielak
Chief Information Officer
David Wages, Md, Phd
Chief Medical Officer
David is responsible for ensuring that iSpecimen meets the medical research needs of customers. This includes ensuring that specimens are of the highest quality and that iSpecimen technology will continue to meet the increasingly sophisticated needs of the academic, pharmaceutical, and government research communities.
Prior to joining iSpecimen, David served as Senior Medical Director at Quintiles, the world’s largest clinical research organization, where he supported both large pharmaceutical companies as well as smaller biotech organizations in a wide variety of clinical oncology programs. David has worked in both start-up biotechs and large pharma. David began his career working on the clinical development of novel drug-device combinations for blood decontamination at Cerus Corporation. He then worked on clinical trials at Wyeth that led to the development of Xyntha®, a drug used to treat hemophilia. After a brief stint assisting institutional investors on healthcare technology opportunities at Leerink-Swann’s Medacorp, David then moved on to ARIAD Pharmaceuticals where he turned to cancer research, working on ARIAD’s mTOR inhibitor for solid tumors as well as initiating ARIAD’s phase I trial for chronic myeloid leukemia drug, Iclusig®. David next joined EMD Serono where he worked on phase I-III trials of immune-agents for oncology. David holds an MD and PhD from the University of Virginia School of Medicine where he focused on the basic science of oncology. He then completed a residency at the University of California, San Francisco and a fellowship in hematopathology at Boston’s Beth Israel hospital.
David Wages, MD, PhD
Chief Medical Officer
Eric Langlois
Chief Revenue Officer
Mr. Langlois has been serving as Chief Revenue Officer since January of 2023, overseeing the departments of Site Development, Marketing, Sales Operations, Sales, and Customer Success. Prior he served as iSpecimen’s SVP of Sales and Business Development since arriving in Jan of 2016 driving results leading to a successful IPO. Prior to joining iSpecimen, Eric served as Global Head of Sales for The Reprocell Group of companies. He helped build and manage a sales teams driven by the demands of integrating four portfolio companies with products and services in Cellular Reprogramming, Stem Cells, 3D cell culture, genomics, and biospecimens. Prior to that, he held rapidly increasing positions from Regional Sales Manager to VP of Sales with Genomics Collaborative, SeraCare Life Sciences, SeqWright, and BioServe. Eric has amassed 25 years of experience in life science research going from bench laboratory science into business development and executive management. Eric and his teams have proven quite successful at driving revenue using a consultative, customer-centric approach. Eric holds a BS in Biotechnology/Biochemistry from Worcester Polytechnic Institute.
Eric Langlois
Chief Revenue Officer
Annette Arnold
Vice President of Sales & Business Development
Annette is responsible for driving and managing all aspects of company sales and business development. In this position, she applies her strategic vision as well as her skills in negotiation, facility management (FM) and management. Additionally, she plays a key role in analyzing and developing the supply partner network in order to meet the demands of iSpecimen’s rapidly expanding customer base.
Annette has over 20 years of experience working in sales. Before joining iSpecimen, Annette was Manager of Business Development at Folio Conversant. There, she was responsible for supporting and growing business within existing accounts, and developing new accounts, through direct customer sales. Prior to Folio Conversant, she moved from Business Administrator to Client Account Manager at Biblioteca. For over a decade, Annette and her teams have established solid relationships with R&D groups, grown business revenue substantially, and streamlined project workflows for vital accounts. Annette holds an AS in Computer Science from Keene State College.
Annette Arnold
Vice President of Sales & Business Development
Carly Lejnieks
Vice President of Marketing
Carly and her team are focused on bringing the unique iSpecimen offering to life science customers who are seeking streamlined, compliant solutions for procuring archived pathology, banked, and prospective or custom-collected human biospecimens. The team is also focused on engaging new partners interested in joining the iSpecimen network, enabling deep and far-reaching access to millions of human biospecimens and patients that have consented to donate them.
Carly has led marketing strategies, integrated programs, and high-growth initiatives for Life Science organizations for more than 20 years. Before joining iSpecimen, she worked as a marketing consultant for more than a decade serving clients in the healthcare and life science industries. Most recently, she managed global, digital marketing and eCommerce programs responsible for driving double-digit growth in the cell culture consumables division of Thermo Fisher Scientific.
Carly Lejnieks
Vice President of Marketing
Evan Cox
Vice President of Product Management
Evan brings nearly 20 years of Product Management and leadership experience to iSpecimen. In his role at iSpecimen, Evan is responsible for creation and management of the long-term roadmap and strategy plan for our industry leading iSpecimen Marketplace application. Prior to joining iSpecimen, Evan held several key senior management roles at Definitive Healthcare Corp., a provider of healthcare commercial intelligence, most recently as Associate Vice President, where he led the product management team. Before that, he held multiple product strategy and decision support roles at Change Healthcare, a healthcare technology company, where he focused on artificial intelligence and natural language processing to streamline existing workflows.
In addition, Mr. Cox co-founded DSE Analytics, a company that used natural language processing to integrate qualitative and quantitative information available on Consumer Assessment of Healthcare Providers and Systems (CAHPS) surveys to deliver providers deep insights into their satisfaction scores. He also served as Senior Product Manager of Data Analytics and Research at Press Ganey Associates and Product Lead of Clinical Data Management at WebMD.
Evan Cox
Senior Vice President of Strategy & Innovation
Board of Directors
The following individuals sit on iSpecimen's board of directors:
Andrew Ross
Board Member
Theresa Mock
Board Member
Steven Gullans
Board Member
John L. Brooks III
Board Member
Elizabeth Graham
Board Member
